A Core–Shell Nanoplatform for Synergistic Enhanced Sonodynamic Therapy of Hypoxic Tumor via Cascaded Strategy
- 10 October 2018
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 7 (22) , e1800819
Abstract
Sonodynamic therapy (SDT) always causes tumor hypoxia aggravation which can induce malignant cell proliferation and drug resistance. To overcome these disadvantages, a cascaded drug delivery system (Lipo/HMME/ACF@MnO2‐AS1411) is constructed for synergistic enhanced sonodynamic therapy. First, hematoporphyrin monomethyl ether (HMME) and acriflavine (ACF) are encapsulated in the lipid layers and the inner aqueous cores of the liposomes, respectively. Then the ultrathin manganese dioxide (MnO2) nanosheets are coated on the surface of the liposomes by using KMnO4 and polyethylene glycol through “one step reduction and modification” method. Furthermore, the nanoparticles are decorated with tumor‐targeting AS1411 aptamer through the phosphate groups on the DNA strand which can bind to Mn sites to obtain Lipo/HMME/ACF@MnO2‐AS1411 delivery system. Herein, HMME can act as a sonosensitizer, and ACF is used to prevent the formation of HIF‐1α/HIF‐1β dimerization to overcome the negative effects after SDT. The Lipo/HMME/ACF@MnO2‐AS1411 delivery system has multiple functions, including codelivery of HMME and ACF, pH/glutathione/ultrasound triple responses, synergistic cascaded enhancement of SDT, precise tumor‐targeting, and magnetic resonance imaging. The in vitro and in vivo results suggest that the Lipo/HMME/ACF@MnO2‐AS1411 delivery system is a promising core–shell nanoplatform for synergistic enhancement of sonodynamic therapy, which can provide a new approach in the related research fields.Keywords
Funding Information
- National Natural Science Foundation of China (81673021, 81573364, 81601597, U1704178, U180410212)
This publication has 51 references indexed in Scilit:
- Surface Engineering of Liposomes for Stealth BehaviorPharmaceutics, 2013
- The application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatmentInternational Journal of Nanomedicine, 2013
- The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomesBiomaterials, 2011
- Study of a novel ultrasonically triggered drug vehicle with magnetic resonance propertiesActa Biomaterialia, 2011
- RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularizationProceedings of the National Academy of Sciences, 2009
- Statistical methods for efficiency adjusted real‐time PCR quantificationBiotechnology Journal, 2008
- Hypoxia and cancerJournal of Molecular Medicine, 2007
- Mechanistic Investigation and Implications of Photodynamic Therapy Induction of Vascular Endothelial Growth Factor in Prostate CancerCancer Research, 2006
- Cellular response to oxidative stress: Signaling for suicide and survival*Journal of Cellular Physiology, 2002
- Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature, 1992